Zymeworks (ZYME) Cash from Investing Activities (2021 - 2026)

Zymeworks' (ZYME) quarterly Cash from Investing Activities came in at $70.0 million in Q1 2026, up 474.28% year-on-year from $12.2 million in Q1 2025, and up 1203.26% quarter-over-quarter from $5.4 million in Q4 2025.

Zymeworks (ZYME) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Zymeworks has disclosed Cash from Investing Activities across 6 years of filings, most recently posting $70.0 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $70.0 million, up 474.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $84.4 million (up 44.95% YoY), and the FY2025 annual result was $26.7 million, down 31.2% from the prior year.
  • Cash from Investing Activities came in at $70.0 million for Q1 2026 at Zymeworks, up from $5.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $72.3 million in Q3 2024 to a low of -$138.2 million in Q1 2023.
  • The 5-year median for Cash from Investing Activities is -$6.2 million (2024), against an average of -$7.4 million.
  • Across the five-year window, Cash from Investing Activities tumbled 1088.21% in 2022 and soared 1129.3% in 2024, its largest moves.
  • Zymeworks' Cash from Investing Activities stood at -$22.1 million in 2022, then soared by 93.94% to -$1.3 million in 2023, then slumped by 364.77% to -$6.2 million in 2024, then surged by 186.39% to $5.4 million in 2025, then jumped by 1203.26% to $70.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at $70.0 million (Q1 2026), $5.4 million (Q4 2025), and $368000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Zymeworks 1.73 Bn 1.36 Bn - 69.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 69.96 Mn
Mar 31, 2026 69.96 Mn
Dec 31, 2025 5.37 Mn
Dec 31, 2025 5.37 Mn
Sep 30, 2025 368,000.00
Sep 30, 2025 368,000.00
Jun 30, 2025 8.75 Mn
Jun 30, 2025 8.75 Mn
Mar 31, 2025 12.18 Mn
Mar 31, 2025 12.18 Mn
Dec 31, 2024 -6.21 Mn
Dec 31, 2024 -6.21 Mn
Sep 30, 2024 72.26 Mn
Sep 30, 2024 72.26 Mn
Jun 30, 2024 -19.97 Mn
Jun 30, 2024 -19.97 Mn
Mar 31, 2024 -7.32 Mn
Mar 31, 2024 -7.32 Mn
Dec 31, 2023 -1.34 Mn
Dec 31, 2023 -1.34 Mn